A research study to evaluate the effects of single doses of NNC0614-0001 in healthy adult volunteers, and participants with hereditary haemochromatosis type 1.
NN7614-7656
Phase 1 other active
Quick answer
A research study to evaluate the effects of single doses of NNC0614-0001 in healthy adult volunteers, and participants with hereditary haemochromatosis type 1. for Hereditary haemochromatosis (HH) type 1 is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Hereditary haemochromatosis (HH) type 1
- Phase
- Phase 1
- Modality
- other
- Status
- active